MET and neoplasm: The free integrin associates with RTKs (e.g., EGFR, HER2, c-Met, Ron kinase), resulting in phosphorylation of tyrosines in the β4 integrin cytoplasmic domain and activation of signaling effectors that drive proliferation, survival and invasion of the tumor cells (11–15).